About RIMONEXT LTD. (2019)
Rimonext Ltd. (2019), headed by Ephraim Lansky, is a new company established to continue the earlier work of Rimonest Ltd. (1999-2018) into the pharmacological potential of pomegranate fruit (Punica granatum). Rimonext's vision is a world aware of its roots in Nature and Spirit. The company's Mission is to create novel complex
pharmaceuticals founded in Nature, especially derived from pomegranate fruit, and to use these pharmaceuticals to open the medicines market worldwide further for natural, complex drugs.